Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.490

+2.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who started this subject	10/21/2003 9:10:06 AM
From: richardred	of 7262

DJ Akzo CEO: Co Interested In Entering Human Vaccines Mkt Dow Jones News Service ~ October 21, 2003 ~ 7:33 am EST (MORE) Dow Jones Newswires 10-21-03 0733ET DJ Akzo CEO:Also Interested In Strengthening Intervet In US (MORE) Dow Jones Newswires 10-21-03 0733ET DJ Akzo/CEO -2: Hopes Pfizer Deal Will Open Way To Others By Elena Berton Of DOW JONES NEWSWIRES LONDON (Dow Jones)--Dutch coatings, chemicals and drugs company Akzo Nobel NV (AKZOY) is looking for ways to break into the human vaccine market, Chief Executive Hans Wijers told Dow Jones Newswires Tuesday in an interview. The company is opening a multipurpose factory in the Netherlands Dec. 1 which will initially manufacture vaccines for its Intervet veterinary operation but could switch to human vaccines if the opportunity presents itself. Wijers said that Akzo Nobel would like to strengthen its veterinary vaccine operations in the U.S. either organically or through acquisitions. (MORE) Dow Jones Newswires 10-21-03 0836ET

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next